Existing Customer

Renew your plan
Refer & Earn
HomeGreater Than Icon
Omkar Pharmachem LtdGreater Than Icon
Omkar Pharmachem Ltd Financials
Company Logo

Omkar Pharmachem Ltd Financial Statement

Omkar Pharmachem Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Mar 2024
Revenue0.14
Operating Expense0.06
Net Profit-0.02
Net Profit Margin-14.29
Earning Per Share-0.02
EBIDTA0.07
Effective Tax Rate75.00

Omkar Pharmachem Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
Total Revenue Annual0.54
Operating Expenses Annual0.23
Operating Profit Annual0.31
Interest Annual0.05
Depreciation0.00
Net Profit Annual0.20
Tax Annual0.07

Omkar Pharmachem Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
Cash Flow at the Beginning0.21
Cash Flow from Operations0.28
Cash Flow from InvestingTBA
Cash Flow from Financing-0.35
Cash Flow at the End0.13

Omkar Pharmachem Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
PBDIT Margin (%)59.26
PBIT Margin (%)59.26
PBT Margin (%)-1,125.93
Net PROFIT Margin (%)37.04
Return On Networth / Equity (%)1.98
Return On Networth /Employed (%)2.95
Return On Assets (%)2.22
Total Debt / Equity (X)0.09
Asset Turnover Ratio (%)0.06

Omkar Pharmachem Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
Fixed Assets Annual0.00
Total Current Assets Annual0.26
Non Current Assets Annual9.47
Total Shareholders Funds Annual9.04
Total Assets Annual9.73

Omkar Pharmachem Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Jul 27, 2024, Omkar Pharmachem Ltd has a market capitalization of 22.67 Cr. Value Research classifies it as a Micro-Cap company.
Yes, Omkar Pharmachem Ltd is debt-free with a debt-to-equity ratio of 0.03.
In FY 2023 , Omkar Pharmachem Ltd recorded a total revenue of approximately 0 Cr marking a significant milestone in the company's financial performance.
Omkar Pharmachem Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.0% and NaN% annually, respectively..
Omkar Pharmachem Ltd's current PE ratio is 119.32.
Omkar Pharmachem Ltd's ROCE averaged 3.0% from the FY ending March 2022 to 2024, with a median of 3.0%. It peaked at 3.2% in March 2023, reflecting strong capital efficiency over the period..
Omkar Pharmachem Ltd's latest EBIT is Rs. 0.28 Cr, surpassing the average EBIT of Rs. 0.29 Cr over the 5 years..